genekam logo
  • usa
    • german
    • russia
    • china
Duissernstr. 65a · 47058 Duisburg · Germany
Tel. +49 203 / 555 858 -31 / 32 / 33 · Fax: +49 203 / 35 82 99
menuicon
slider
Latest News:

21.01.2020
Genekam has developed novel corona virus 2020 (Wuhan strain specific) kits and potential therapeutic molecules.

read more
Latest News:

21.01.2020
3D Genomemedicine Inc is going to operate in USA

read more
  • ++BREAKING NEWS (26.05.2020)++

    Plasma therapy accelerator (SARS-Hunter): a new solution for better antibody therapy for all coronavirus patients.

    read more
  • MEDICA 2021

    Visit us at MEDICA in Duesseldorf, Germany:
    15.11. - 18.11.21

    read more
  • BIO CEO & Investor Digital Conference

    Visit us at BIO CEO & Investor Digital Conference New York, USA:
    16.02. - 18.02.2021

    read more
  • INVEST 2021

    Visit us at INVEST in Stuttgart, Germany:
    23.03. - 24.04.21

    read more
  • LSX World Congress

    Visit us at LSX World Congress 2021 Virtual London, UK:
    01.02 - 05.02.2021

    read more
  • Merry Christmas 2020

    We wish you a merry Christmas and a happy new year 2021

    read more

Skeletal myogenic differentiation media (10X)

Cat.
No.		 Name of ready to use
PCR Kit		 Storage DOC Amount Price*
STEM08Skeletal myogenic differentiation media (10X) -20°C 10ml100,-€

Genekam Skeletal myogenic differentiation (Steril Product)*


Kit contents: STEM08 Genekam Skeletal myogenic differentiation media: 10X = 10ml (store at -20°C)
Final Myogenic differentiation media: add 10ml of Genekam Myogenic differentiationmedia into 90 ml DMEM + 15% FCS. It is called Final myogenic differentiation media.

under Construction

* only for research use.
TOP